Vulvar cancer mainly occurs in women over 50 years old, though patients in their 30s may also develop the disease. Treatment options include local surgery, lymph node dissection, radiotherapy, and combined chemotherapy or targeted therapy. Without timely treatment, lymphatic and distant metastases may occur, increasing treatment complexity and affecting survival rates.
Immune reconstruction cell therapy activates the patient’s own immune cells to recognize and eliminate residual or microscopic vulvar cancer lesions, showing good results in aiding postoperative recovery and recurrence control. This therapy offers strong targeting ability, low side effects, and is suitable for early adjuvant use or recurrence prevention.
① CAR-T or CIK cells enhance recognition of tumor cells
② Combined with radiotherapy, it can improve immune sensitivity
③ Clears postoperative residuals and reduces groin lymph node recurrence rate
④ Delays disease progression and achieves long-term stable control
In actual treatment, patients undergoing surgery, radiotherapy, or chemotherapy often face immune dysfunction, increased infection risks, and slow recovery. To help patients better sustain treatment, improve tolerance, and enhance quality of life, phased immune reconstruction programs must be scientifically designed for different cycles.
● Short-term plan: Rapidly boost immunity through immune cell reinfusion to strengthen anti-tumor treatment effects.
● Mid-term plan: Reduce side effects of conventional treatments, promote recovery, and ensure completion of standardized therapy.
● Long-term plan: Comprehensive improvement of immunity through immune cell reconstruction, gut immunity restoration, elemental immunity rebuilding, and immune nutrition support, thereby improving quality of life and prolonging survival.
1. Surgical Resection
Surgery is the first-line treatment, requiring tumor removal and groin lymph node dissection. Patients with small lesions may undergo local resection, while those with extensive disease may require reconstructive surgery to restore vulvar structure and preserve function.
2. Radiotherapy
Applied in cases of postoperative residuals or positive lymph nodes, or as the main treatment for patients unfit for surgery. Modern radiotherapy techniques (such as IMRT) offer precise targeting and protect normal tissues.
3. Chemotherapy and Targeted Therapy
For advanced cases, platinum- or taxane-based combination chemotherapy may be used. Targeted drugs aimed at the EGFR/PI3K pathway can enhance control, serving as an effective supplement for patients unsuitable for surgery or radiotherapy.
4. Minimally Invasive Interventions
For elderly or recurrent patients, radiofrequency ablation or laser palliative therapy may be applied. These methods involve minimal trauma, faster recovery, but mainly provide short-term symptom relief rather than cure.
5. Rehabilitation and Psychological Support
Post-treatment rehabilitation is essential to restore vulvar function and sexual quality of life, alongside psychological counseling to relieve anxiety and self-image issues.
Experts at United Life International Medical Center believe that vulvar cancer requires individualized treatment plans and recommend combining immune reconstruction cell therapy with conventional approaches to improve cure rates, reduce recurrence, and enhance quality of life. Long-term follow-up and functional rehabilitation are equally indispensable.